MACURE PHARMA ApS: Financial statements 2025
CVR: 35234748
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
MACURE PHARMA ApS (CVR 35234748) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 47,649,382 and a net result of DKK 11,054,004 compared with DKK 8,495,013 the year before. That is an increase of 22% compared with the year before. Equity in the 2025 report amounted to DKK 18,033,649. The solvency ratio was 11.1%. The company had 21 employees in the financial year.
- Gross Profit
- DKK 47,649,382
- Profit/Loss
- DKK 11,054,004
- Equity
- DKK 18,033,649
- Total Assets
- DKK 162,201,731
- Employees
- 21
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 47.6 mio. | 11.1 mio. | 18 mio. | 21 |
| 2024 | - | 39.1 mio. | 8.5 mio. | 15 mio. | 13 |
| 2023 | - | 24.2 mio. | 8.8 mio. | 14.2 mio. | 13 |
| 2022 | - | 37.5 mio. | 17.9 mio. | 23.4 mio. | 10 |
| 2021 | - | 25 mio. | 5 mio. | 10.5 mio. | 6 |
Official annual report
How creditworthy is MACURE PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
MACURE PHARMA ApS has won the tender "Amgros 2026 1.607.a" issued by Amgros I/S worth 60,481,552 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2026 1.601.a" issued by Amgros I/S worth 331,750,548 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2026 1.1201.a" issued by Amgros I/S worth 358,514,920 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2026 2.1301.a" issued by Amgros I/S worth 39,781,779 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2026 2.1302.b" issued by Amgros I/S worth 161,990,275 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2026 1.1241.a" issued by Amgros I/S worth 19,000,000 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2026 1.201.a" issued by Amgros I/S worth 286,787,957 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2026 1.604.a" issued by Amgros I/S worth 501,367,776 DKK.
MACURE PHARMA ApS has won the tender "Amgros 2026 2.3.b" issued by Amgros I/S worth 382,769,201 DKK.
MACURE PHARMA ApS has published its annual report for 2024. Gross profit came to DKK 39,051,226, and the net result was DKK 8,495,013.
About MACURE PHARMA ApS
MACURE PHARMA ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2013. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Mads Renlef Henningsen and Lars Mark Poulsen. The company is owned by Nest Egg ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 47,649,382 and a net result of DKK 11,054,004 compared with DKK 8,495,013 the year before. Equity in the 2025 report amounted to DKK 18,033,649.